Therapeutic manufacturing

GMP CDMO Services for
Phase 3 | PPQ | Commercial Supply

Eurogentec has established experience supporting Phase 3 and PPQ programs across GMP plasmid DNA, recombinant proteins, and IVT-based mRNA manufacturing.

View our offer

Established GMP manufacturing
for late-stage programs

Three GMP modalities
for late-stage manufacturing

From microbial expression or in vitro transcription, our GMP manufacturing platforms are designed
to deliver consistent, compliant, and scalable drug-substance production for Phase 3, PPQ campaign
and commercial phase.

Combined with experienced project teams, our established GMP Quality Management System
help shorten the path from process development to validated GMP manufacturing.

Contact us

GMP plasmid DNA

Our GMP plasmid DNA manufacturing uses microbial production systems to deliver plasmid DNA up to kg-scale for advanced therapies.

We produce plasmids that can serve either as starting materials for example, in mRNA, AAV (adeno-associated virus) or lentiviral vector manufacturing or as active pharmaceutical ingredients (API) when the plasmid itself is the therapeutic component.

Each batch is manufactured under GMP conditions, with complete traceability, release testing, and documentation suitable for Phase 3 and commercial requirements.






Plasmid Manufacturing

GMP mRNA

Eurogentec offers GMP in vitro transcription (IVT) mRNA manufacturing, supporting development from early-stage research to Phase 3 and commercial stage.

Our process covers template preparation, enzyme-based IVT synthesis, and scalable purification , ensuring consistent, GMP-grade drug-substance mRNA.

With almost a decade of mRNA process development expertise, Eurogentec provides flexible production capacities from microgram to 50 g.

Final fill and finish operations are managed by your selected partner or KEGT's partners, ensuring seamless project handover from drug substance to drug product.



RNA Manufacturing

GMP recombinant protein

We provide GMP manufacturing of recombinant proteins using microbial expression systems such as E. coli and P. pastoris (K. phaffii).

Our services cover the clone selection, fermentation and purification to deliver drug-substance-ready proteins under fully documented GMP processes.

In addition to standard recombinant proteins, Eurogentec also manufactures protein conjugates and VHH antibody fragments, expanding the range of microbial-based products we can support.

These capabilities are tailored for Phase 3 programs and PPQ readiness, including scale-up qualification and supply chain control.



Protein Manufacturing

Late-stage manufacturing experience

Our Quality Management System (QMS) supports projects from early development to
commercialization. Working with biotech and pharmaceutical companies in both human and
veterinary health, Eurogentec has built experience across all stages of process validation,
contributing to a robust GMP manufacturing framework.

Contact us